Follow the Keenova Therapeutics plc share price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). The latest transaction was reported on 23 July 2026 (Retenue fiscale). Among the most active insiders: Silver Point Capital L.P.. All data is openly available.
31
Insider Decl.
n/a
Thresholds
€107m
6 ops.
Buy Volume
n/a
n/a
Sell Volume
28Σ signal
Buys €107mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Keenova Therapeutics plc is a biopharmaceutical company focused on developing innovative treatments for serious diseases. It is listed on NASDAQ under the ticker KOVA.